DONALD EUGENE THOMAS M.D. NPI 1730167545

NPI Details

Donald Eugene Thomas, M.D. is a rheumatology internal medicine in Greenbelt, MD with 37 years of experience. The provider is an internist who treats diseases of joints, muscle, bones and tendons. This specialist diagnoses and treats arthritis, back pain, muscle strains, common athletic injuries and collagen diseases. Donald Eugene Thomas, M.D. NPI is 1730167545. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: BAYLOR COLLEGE OF MEDICINE
Graduation Year:1989

The provider's business location address is:

7300 HANOVER DR
SUITE 201
GREENBELT, MD
ZIP 20770-202
Phone: (301) 345-5600
Fax: (301) 345-3105

The NPI 1730167545 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS:J0129)
• Injection, belimumab, 10 mg (HCPCS:J0490)
• Injection, golimumab, 1 mg, for intravenous use (HCPCS:J1602)
• Injection, infliximab, excludes biosimilar, 10 mg (HCPCS:J1745)
• Injection, rituximab, 10 mg (HCPCS:J9312)
• Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg (HCPCS:J3304)
• Measurement of antibody for assessment of autoimmune disorder, any method (HCPCS:86235)
• Injection, zoledronic acid, 1 mg (HCPCS:J3489)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Measurement c-reactive protein for detection of infection or inflammation (HCPCS:86140)
• Measurement of complement (immune system proteins), antigen, (HCPCS:86160)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Complete ultrasound scan of joint (HCPCS:76881)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Vitamin d-3 level (HCPCS:82306)
• Injection, methylprednisolone acetate, 40 mg (HCPCS:J1030)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Automated urinalysis test (HCPCS:81003)
• Measurement of dna antibody, single stranded (HCPCS:86226)
• Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or (HCPCS:G2212)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Injection, triamcinolone acetonide, not otherwise specified, 10 mg (HCPCS:J3301)
• Measurement of dna antibody, native or double stranded (HCPCS:86225)
• Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromise (HCPCS:M0220)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Red blood cell sedimentation rate, to detect inflammation, non-automated (HCPCS:85651)
• Aspiration and/or injection of fluid large joint using ultrasound guidance (HCPCS:20611)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
• Injection, methylprednisolone sodium succinate, up to 125 mg (HCPCS:J2930)
• Magnesium level (HCPCS:83735)
• Folic acid level, serum (HCPCS:82746)
• Aspiration and/or injection of fluid from large joint (HCPCS:20610)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Hemoglobin a1c level (HCPCS:83036)
• Dxa bone density measurement of hip, pelvis, spine (HCPCS:77080)
• Injection, methylprednisolone sodium succinate, up to 40 mg (HCPCS:J2920)
• Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage (HCPCS:90694)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Parathormone (parathyroid hormone) level (HCPCS:83970)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Uric acid level, blood (HCPCS:84550)
• Adm sarscov2 50mcg/0.25mlbst (HCPCS:0064A)
• Testing for presence of drug, read by direct observation (HCPCS:80305)
• Fee covid-19 vac 13 res (HCPCS:0124A)
• Hyaluronan or derivative, gel-one, for intra-articular injection, per dose (HCPCS:J7326)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Fee covid-19 vac 14 res (HCPCS:0134A)
• Adm sarscov2 30mcg/0.3ml bst (HCPCS:0004A)
• Ferritin (blood protein) level (HCPCS:82728)
• Analysis of substance using immunoassay technique, multiple step method (HCPCS:83516)
• Injection of anesthetic agent and/or steroid into suprascapular shoulder nerve (HCPCS:64418)
• Creatine kinase (cardiac enzyme) level, total (HCPCS:82550)
• Iron level (HCPCS:83540)
• Iron binding capacity (HCPCS:83550)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Hyaluronan or derivative, monovisc, for intra-articular injection, per dose (HCPCS:J7327)
• Thyroxine (thyroid chemical), free (HCPCS:84439)
• Rheumatoid factor level (HCPCS:86431)
• Injection of trigger points, 3 or more muscles (HCPCS:20553)
• Ultrasonic guidance for needle placement (HCPCS:76942)

The enumeration date for this NPI number is 1/3/2006 and was last updated on 12/30/2010.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.